With the U.S.
government spending billions towards a COVID-19 vaccine, it's been a gold rush for insiders speculating on the winner of the vaccine race.
But our Garrett Baldwin's more interested on these two short- and long-term trades that'll get a huge bounce once a vaccine emerges…